Frequency Modulated Translocational Oscillations of Nrf2 Mediate the Antioxidant Response Element Cytoprotective Transcriptional Response

Antioxidants and Redox Signaling

Volumn 23, Issue 7, 2015, Pages 613-629

  Xue, Mingzhan ^a   Momiji, Hiroshi ^b   Rabbani, Naila ^a,b   Barker, Guy ^b   Bretschneider, Till ^b   Shmygol, Anatoly ^a   Rand, David A ^b   Thornalley, Paul J ^a,b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALYCULIN A; FERRITIN; GAMMA GLUTAMYLCYSTEINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE REDUCTASE; GLYCOGEN SYNTHASE KINASE 3BETA; HEME OXYGENASE; HISTONE DEACETYLASE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MESSENGER RNA; PGAM5 PROTEIN; PHENETHYL ISOTHIOCYANATE; PROTEIN; PROTEIN KINASE FYN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR NRF2; TRANSKETOLASE; UNCLASSIFIED DRUG; CARRIER PROTEIN; MITOCHONDRIAL PROTEIN; NFE2L2 PROTEIN, HUMAN; PGAM5 PROTEIN, HUMAN; PHOSPHOPROTEIN PHOSPHATASE;

ACETYLATION; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL STRESS; CELLULAR DISTRIBUTION; CYTOPLASM; EC50; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NEGATIVE FEEDBACK; OXYGEN CONCENTRATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; CELL LINE; GENETICS; METABOLISM; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN TRANSPORT; TRANSCRIPTION INITIATION;

ANTIOXIDANT RESPONSE ELEMENTS; CARRIER PROTEINS; CELL LINE; CELL NUCLEUS; CYTOPLASM; HUMANS; MITOCHONDRIAL PROTEINS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN TRANSPORT; TRANSCRIPTIONAL ACTIVATION;

EID: 84940395498     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.5962     Document Type: Article

References (75)

1. Apopa PL, He XQ, and Ma Q. Phosphorylation of nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells. J Biochem Mol Toxicol 22: 63-76, 2008.
2. Baird L and Dinkova-Kostova A. The cytoprotective role of the Keap1/Nrf2 pathway. Arch Toxicol 85: 241-272, 2011.
3. Bertl E, Bartsch H, and Gerhauser C. Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol Cancer Ther 5: 575-585, 2006.
4. Brockwell PJ and Davis RA. Introduction to Time Series and Forecasting. New York: Springer, 2002, p. 437.
5. Burton NC, Kensler TW, and Guilarte TR. In vivo modulation of the Parkinsonian phenotype by Nrf2. Neurotoxicology 27: 1094-1100, 2006
6. Cai L, Dalal CK, Elowitz MB. Frequency-modulated nuclear localization bursts coordinate gene regulation. Nature 455: 485-490, 2008.
7. Clarke JD, Hsu A, Riedl K, Bella D, Schwartz SJ, Stevens JF, and Ho E. Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol Res 64: 456-463, 2011.
8. Collins AR, Lyon CJ, Xia XF, Liu JZ, Tangirala RK, Yin F, Boyadjian R, Bikineyeva A, Pratico D, Harrison DG, and Hsueh WA. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res 104: e42-e54, 2009.
9. Copple IM, Lister A, Obeng AD, Kitteringham NR, Jenkins RE, Layfield R, Foster BJ, Goldring CE, and Park BK. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway. J Biol Chem 285: 16782-16788, 2010.
10. Cullinan SB, Gordan JD, Jin J, Harper JW, and Diehl JA. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 24: 8477-8486, 2004.
11. Du CJ, Marcello M, Spiller DG, White MRH, and Bretschneider T. Interactive segmentation of clustered cells via geodesic commute distance and constrained density weighted Nystrom method. Cytometry A 77A: 1137-1147, 2010.
12. Ebato C, Uchida T, Arakawa M, Komatsu M, Ueno T, Komiya K, Azuma K, Hirose T, Tanaka K, Kominami E, Kawamori R, Fujitani Y, and Watada H. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab 8: 325-332, 2008.
13. Fortina P and Surrey S. Digital mRNA profiling. Nat Biotechnol 26: 293-294, 2008.
14. Gao L, Wang JK, Sekhar KR, Yin HY, Yared NF, Schneider SN, Sasi S, Dalton TP, Anderson ME, Chan JY, Morrow JD, and Freeman ML. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem 282: 2529-2537, 2007.
15. Gillespie DT. Exact stochastic simulation of coupled chemical-reactions. J Phys Chem 81: 2340-2361, 1977.
16. Hayashi R, Himori N, Taguchi K, Ishikawa Y, Uesugi K, Ito M, Duncan T, Tsujikawa M, Nakazawa T, Yamamoto M, and Nishida K. The role of the Nrf2-mediated defense system in corneal epithelial wound healing. Free Radic Biol Med 61: 333-342, 2013.
17. Hubbard GP, Wolffram S, de Vos R, Bovy A, Gibbins JM, and Lovegrove JA. Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: a pilot study. Br J Nutr 96: 482-488, 2006.
18. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, and Mann GE. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94: 609-616, 2004.
19. Itoh K, Wakabayashi N, Katoh Y, Ishii T, O'Connor T, and Yamamoto M. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8: 379-391, 2003.
20. Jacquet M, Renault G, Lallet S, De Mey J, and Goldbeter A. Oscillatory nucleocytoplasmic shuttling of the general stress response transcriptional activators Msn2 and Msn4 in Saccharomyces cerevisiae. J Cell Biol 161: 497-505, 2003.
21. Jain AK, Bloom DA, and Jaiswal AK. Nuclear import and export signals in control of Nrf2. J Biol Chem 280: 29158-29168, 2005.
22. Jain AK and Jaiswal AK. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J Biol Chem 281: 12132-12142, 2006.
23. Jain AK and Jaiswal AK. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NFE2 related factor 2. J Biol Chem 282: 16502-16510, 2007.
24. Jeong WS, Keum YS, Chen C, Jain MR, Shen GX, Kim JH, Li WG, and Kong ANT. Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells. J Biochem Mol Biol 38: 167-176, 2005.
25. Kapeta S, Chondrogianni N, and Gonos ES. Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts. J Biol Chem 285: 8171-8184, 2010.
26. Kaspar JW and Jaiswal AK. Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression. FASEB J 25: 1076-1087, 2010.
27. Katsuoka F, Motohashi H, Ishii T, Aburatani H, Engel JD, and Yamamoto M. Genetic evidence that small Maf proteins are essential for the activation of antioxidant response elementdependent genes. Mol Cell Biol 25: 8044-8051, 2005.
28. Kobayashi A, Kang MI, Watai Y, Tong KI, Shibata T, Uchida K, and Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 26: 221-229, 2006.
29. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura Si, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, and Yamamoto M. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12: 213-223, 2010.
30. Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, Wolff B, Yoshida M, and Horinouchi S. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci USA 96: 9112-9117, 1999.
31. Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB, and Alon U. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 36: 147-150, 2004.
32. Larance M, Ahmad Y, Kirkwood KJ, Ly T, and Lamond AI. Global subcellular characterization of protein degradation using quantitative proteomics. Mol Cell Proteomics 12: 638-650, 2013.
33. Lau A, Tian W, Whitman SA, and Zhang DND. The predicted molecular weight of Nrf2: it is what it is not. Antioxid Redox Signal 18: 91-93, 2013.
34. Lee OH, Jain AK, Papusha V, and Jaiswal AK. An autoregulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance. J Biol Chem 282: 36412-36420, 2007.
35. Li Y, Zhang T, Korkaya H, Liu S, Lee HF, Newman B, Yu Y, Clouthier SG, Schwartz SJ, Wicha MS, and Sun D. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res 16: 2580-2590, 2010.
36. Lo SC and Hannink M. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated keap1-dependent ubiquitin ligase complex. J Biol Chem 281: 37893-37903, 2006.
37. Lo SC and Hannink M. PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria. Exp Cell Res 314: 1789-1803, 2008.
38. Lolli G, Cozza G, Mazzorana M, Tibaldi E, Cesaro L, Donella-Deana A, Meggio F, Venerando A, Franchin C, Sarno S, Battistutta R, and Pinna LA. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight. Biochemistry 51: 6097-6107, 2012.
39. Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, Shyr C, Wakabayashi N, Kensler TW, Wasserman WW, and Biswal S. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38: 5718-5734, 2010.
40. Matsuo M, Sasaki N, Saga K, and Kaneko T. Cytotoxicity of flavonoids toward cultured normal human cells. Biol Pharmaceut Bull 28: 253-259, 2005.
41. Mercado N, Thimmulappa R, Thomas CMR, Fenwick PS, Chana KK, Donnelly LE, Biswal S, Ito K, and Barnes PJ. Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress. Biochem Biophys Res Commun 406: 292-298, 2011.
42. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, and Motohashi H. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22: 66-79, 2012.
43. Nelson DE, Ihekwaba AEC, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, Edwards SW, McDowell HP, Unitt JF, Sullivan E, Grimley R, Benson N, Broomhead D, Kell DB, and White MRH. Oscillations in NF-kB signaling control the dynamics of gene expression. Science 306: 704-708, 2004.
44. Okawa H, Motohashi H, Kobayashi A, Aburatani H, Kensler TW, and Yamamoto M. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun 339: 79-88, 2006.
45. Pearson KJ, Lewis KN, Price NL, Chang JW, Perez E, Cascajo MV, Tamashiro KL, Poosala S, Csiszar A, Ungvari Z, Kensler TW, Yamamoto M, Egan JM, Longo DL, Ingram DK, Navas P, and de Cabo R. Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction. Proc Natl Acad Sci USA 105: 2325-2330, 2008.
46. Pi J, Bai Y, Reece JM, Williams J, Liu D, Freeman ML, Fahl WE, Shugar D, Liu J, Qu W, Collins S, and Waalkes MP. Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic Biol Med 42: 1797-1806, 2007.
47. Rauh D, Fischer F, Gertz M, Lakshminarasimhan M, Bergbrede T, Aladini F, Kambach C, Becker CFW, Zerweck J, Schutkowski M, and Steegborn C. An acetylome peptide microarray reveals specificities and deacetylation substrates for all human sirtuin isoforms. Nat Commun 4: 3327, 2013.
48. Reddy NM, Kleeberger SR, Yamamoto M, Kensler TW, Scollick C, Biswal S, and Reddy SP. Genetic dissection of the Nrf2-dependent redox signaling-regulated transcriptional programs of cell proliferation and cytoprotection. Physiol Genom 32: 74-81, 2007.
49. Ren D, Villeneuve NF, Jiang T, Wu T, Lau A, Toppin HA, and Zhang DD. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci USA 108: 1433-1438, 2011.
50. Rose JL, Huang H, Wray SF, and Hoyt DG. Integrin engagement increases histone H3 acetylation and reduces histone H1 association with DNA in murine lung endothelial cells. Mol Pharmacol 68: 439-446, 2005
51. Shankaran H, Ippolito DL, Chrisler WB, Resat H, Bollinger N, Opresko LK, Wiley HS. Rapid and sustained nuclear-cytoplasmic ERK oscillations induced by epidermal growth factor. Mol Syst Biol 5: 332, 2009.
52. Smirnova Natalya A, Haskew-Layton Renee E, Basso M, Hushpulian Dmitry M, Payappilly Jimmy B, Speer Rachel E, Ahn Y-H, Rakhman I, Cole Philip A, Pinto John T, Ratan Rajiv R, and Gazaryan Irina G. Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators. Chem Biol 18: 752-765.
53. Sun Z, Zhang S, Chan JY, and Zhang DD. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol Cell Biol 27: 6334-6349, 2007.
54. Swingle M, Ni L, and Honkanen R. Small-molecule inhibitors of Ser/Thr protein phosphatases. In: Protein Phosphatase Protocols, edited by Moorhead G. New York: Springer, 2007. pp. 23-38.
55. Taguchi K, Motohashi H, and Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16: 123-140, 2011.
56. Takaya K, Suzuki T, Motohashi H, Onodera K, Satomi S, Kensler TW, and Yamamoto M. Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. Free Radic Biol Med 53: 817-827, 2012.
57. Takeda K, Komuro Y, Hayakawa T, Oguchi H, Ishida Y, Murakami S, Noguchi T, Kinoshita H, Sekine Y, Iemura Si, Natsume T, and Ichijo H. Mitochondrial phosphoglycerate mutase 5 uses alternate catalytic activity as a protein serine/threonine phosphatase to activate ASK1. Proc Natl Acad Sci USA 106: 12301-12305, 2009.
58. Tan W-F, Lin L-P, Li M-H, Zhang Y-X, Tong Y-G, Xiao D, and Ding J. Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur J Pharmacol 459: 255-262, 2003.
59. Tanigawa S, Fujii M, and Hou DX. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radic Biol Med 42: 1690-1703, 2007.
60. Theodore M, Kawai Y, Yang JQ, Kleshchenko Y, Reddy SP, Villalta F, and Arinze IJ. Multiple nuclear localization signals function in the nuclear import of the transcription factor nrf2. J Biol Chem 283: 8984-8994, 2008.
61. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, and Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide array. Cancer Res 62: 5196-5203, 2002.
62. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang M, Kobayashi A, Yamamoto M, Kensler TW, and Talalay P. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 101: 2040-2045, 2004.
63. Wang W, Winlove CP, and Michel CC. Oxygen partial pressure in outer layers of skin of human finger nail folds. J Physiol 549: 855-863, 2003.
64. Wang X, Tomso DJ, Chorley BN, Cho HY, Cheung VG, Kleeberger SR, and Bell DA. Identification of polymorphic antioxidant response elements in the human genome. Hum Mol Genet 16: 1188-1200, 2007.
65. Wang Z, Jiang H, Chen S, Du F, and Wang X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148: 228-243, 2012.
66. Xu K and Thornalley PJ. Involvement of GSH metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitro. Biochem Pharmacol 61: 165-177, 2001.
67. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, and Thornalley PJ. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 57: 2809-2817, 2008.
68. Xue M, Rabbani N, Momiji H, Imbasi P, Anwar MM, Kitteringham NR, Park BK, Souma T, Moriguchi T, Yamamoto M, and Thornalley PJ. Transcriptional control of glyoxalase 1 by Nrf2 provides a stress responsive defence against dicarbonyl glycation. Biochem J 443: 213-222, 2012.
69. Xue P, Hou Y, Chen Y, Yang B, Fu J, Zheng H, Yarborough K, Woods CG, Liu D, Yamamoto M, Zhang Q, Andersen ME, and Pi J. Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome. Diabetes 62: 845-854, 2013.
70. Yagishita Y, Fukutomi T, Sugawara A, Kawamura H, Takahashi T, Pi JB, Uruno A, and Yamamoto M. Nrf2 protects pancreatic beta-cells from oxidative and nitrosative stress in diabetic model mice. Diabetes 63: 605-618, 2014.
71. Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H, and Yamamoto M. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 28: 2758-2770, 2008.
72. Yokoyama T, Kamata Y, and Ohtsuki K. Casein kinase 2 (CK2)-mediated reduction of the activities of Src family tyrosine kinases in vitro. Biol Pharmaceut Bull 27: 1895-1899, 2004.
73. Yoshiura S, Ohtsuka T, Takenaka Y, Nagahara H, Yoshikawa K, and Kageyama R. Ultradian oscillations of Stat, Smad, and Hes1 expression in response to serum. Proc Natl Acad Sci USA 104: 11292-11297, 2007.
74. Zhang DD and Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23: 8137-8151, 2003.
75. Zhou W, Lo SC, Liu JH, Hannink M, and Lubahn DB. ERR-beta: a potent inhibitor of Nrf2 transcriptional activity. Mol Cell Endocrinol 278: 52-62, 2007.